Search

Search Constraints

You searched for: Author/Creator Capri, Giuseppe

Search Results

1. Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis. (December 2020)

2. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: A randomized clinical trial (INT09/98). Issue 6 (5th December 2013)

3. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: A randomized clinical trial (INT09/98). Issue 6 (5th December 2013)

4. Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients. (April 2021)

5. Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer. Issue 7 (July 2021)

7. Sentinel Node Biopsy Alone or With Axillary Dissection in Breast Cancer Patients After Primary Chemotherapy: Long-Term Results of a Prospective Interventional Study. Issue 5 (15th November 2022)

8. Single Institution trial of anthracycline‐ and taxane‐based chemotherapy for operable breast cancer: The ASTER study. Issue 2 (27th February 2019)